Medicare Enrolled
Dr. Bikram Verma Ansil, MD
Gastroenterology · Dayton, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Verma Ansil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verma Ansil?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Verma Ansil
Dr. Bikram Verma Ansil is a gastroenterology specialist in Dayton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Verma Ansil performed 6,131 Medicare services across 1,253 unique beneficiaries.
Between the years covered by Open Payments, Dr. Verma Ansil received a total of $11,126 from 43 pharmaceutical and/or device companies across 683 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Verma Ansil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in OH
$11,126 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,131
Medicare services
Top 3% in OH for gastroenterology
1,253
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~307 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
4,805 | $17 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
256 | $89 | $213 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
234 | $51 | $470 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
136 | $111 | $354 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
110 | $118 | $692 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
107 | $96 | $582 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
79 | $178 | $610 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
77 | $204 | $909 |
| Esophageal motility study A test that evaluates the movement and function of the esophagus. |
52 | $153 | $568 |
| Esophageal function monitoring via nasal tube This procedure involves monitoring and recording esophageal function using a tube inserted through the nose that contains electrodes. |
52 | $127 | $542 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
33 | $47 | $340 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
31 | $172 | $610 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $60 | $153 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
26 | $135 | $610 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $63 | $136 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $90 | $218 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
19 | $75 | $420 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
19 | $550 | $2,369 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $75 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
78.9% high complexity
8.4% medium
12.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,126
Total received (2018-2024)
Avg $1,589/year across 7 years
Top 20% in OH for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
683
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,126 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,328
2023
$1,956
2022
$1,342
2021
$1,678
2020
$834
2019
$1,324
2018
$1,664
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$764
GENZYME CORPORATION
$306
Takeda Pharmaceuticals U.S.A., Inc.
$242
PFIZER INC.
$183
Regeneron Healthcare Solutions, Inc.
$133
Janssen Biotech, Inc.
$122
Celgene Corporation
$110
Ipsen Biopharmaceuticals, Inc
$108
QOL Medical, LLC
$69
Ardelyx, Inc.
$65
Lilly USA, LLC
$59
Daiichi Sankyo Inc.
$33
IRONWOOD PHARMACEUTICALS, INC
$29
E.R. Squibb & Sons, L.L.C.
$25
Madrigal Pharmaceuticals
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
AIMMUNE THERAPEUTICS, INC.
$16
Organon Llc
$14
EVOKE PHARMA, INC.
$13
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$1,580
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,276
ABBVIE INC.
$1,260
PFIZER INC.
$1,013
Takeda Pharmaceuticals U.S.A., Inc.
$880
AbbVie, Inc.
$804
GENZYME CORPORATION
$556
Celgene Corporation
$476
Janssen Biotech, Inc.
$349
INTERCEPT PHARMACEUTICALS, INC.
$303
Synergy Pharmaceuticals Inc
$281
Allergan Inc.
$250
QOL Medical, LLC
$194
Daiichi Sankyo Inc.
$171
RedHill Biopharma Inc.
$170
Regeneron Healthcare Solutions, Inc.
$160
Gilead Sciences, Inc.
$152
Janssen Scientific Affairs, LLC
$125
Ipsen Biopharmaceuticals, Inc
$108
Ironwood Pharmaceuticals, Inc
$99
Intercept Pharmaceuticals, Inc.
$95
Romark Laboratories, LC
$91
Ardelyx, Inc.
$79
Ethicon US, LLC
$74
Merck Sharp & Dohme Corporation
$74
Shionogi Inc
$63
Lilly USA, LLC
$59
Braintree Laboratories, Inc.
$48
IRONWOOD PHARMACEUTICALS, INC
$45
Ferring Pharmaceuticals Inc.
$39
Amgen Inc.
$32
Shire North American Group Inc
$28
E.R. Squibb & Sons, L.L.C.
$25
Nestle HealthCare Nutrition Inc.
$25
Organon LLC
$24
Madrigal Pharmaceuticals
$19
AIMMUNE THERAPEUTICS, INC.
$16
Evoke Pharma, Inc.
$16
Prometheus Laboratories Inc.
$14
Organon Llc
$14
EVOKE PHARMA, INC.
$13
Merck Sharp & Dohme LLC
$13
Alfasigma USA, Inc.
$12
Top 3 companies account for 37.0% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CLENPIQ · CREON · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · GIMOTI · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Movantik · Mulpleta · OCALIVA · OMVOH · PLENVU · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VELSIPITY · VIBERZI · VOWST · XELJANZ · XIFAXAN · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
68
Per 100K population
12.7
County median income
$64,403
Nearest hospital
KETTERING HEALTH MAIN CAMPUS
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Verma Ansil is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with low-engagement industry engagement in the top 20% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Verma Ansil experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Verma Ansil performed 4,805 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verma Ansil receive payments from pharmaceutical companies?
Yes. Dr. Verma Ansil received a total of $11,126 from 43 companies across 683 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verma Ansil's costs compare to other gastroenterologists in Dayton?
Dr. Verma Ansil's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verma Ansil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Dayton
Browse gastroenterologists in Dayton ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in OH
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in OH
Which OH gastroenterologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology